查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1470585

CRISPR 技术市场：按产品、应用和最终用户划分 - 2024-2030 年全球预测

CRISPR Technology Market by Offering (Product, Services), Application (Agricultural, Biomedical, Industrial), End User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年CRISPR技术市场规模为32.5亿美元，预计2024年将达到37.7亿美元，2030年将达到94.9亿美元，复合年增长率为16.52%。

成簇规则间隔短回文重复序列 (CRISPR) 是源自细菌防御机制的高度精确且高效的基因组编辑工具，可对生物体基因组内的 DNA 序列进行有针对性的操作。这种创新的生物技术工具能够利用 RNA 引导的 Cas9 核酸酶进行精确的基因组编辑，从而促进医疗保健、农业和生质能源产业的标靶基因修饰。研究活动资金的增加、基因治疗的进步、遗传病患病率的增加以及对更有效率作物生产方法的需求正在推动 CRISPR 技术的使用增加。然而，围绕基因编辑（特别是在人类生殖细胞中）的伦理问题以及各个地区的监管障碍可能会阻碍 CRISPR 产品的采用和商业化。然而，药物发现的进步包括创造具有更高营养价值和抗病虫害能力的新型作物，以及使用 CRISPR 系统针对特定标靶筛检大型化合物库，为 CRISPR 创造了利润丰厚的机会。

主要市场统计
基准年[2023] 32.5亿美元
预测年份 [2024] 37.7亿美元
预测年份 [2030] 94.9亿美元
复合年增长率（%） 16.52%

提供的 CRISPR套件和试剂的使用迅速增加，研究活动和产品改进取得进展

CRISPR 技术中使用的酵素是基因编辑的关键组件，其中 Cas9 是最常用的酵素。这些酵素充当分子剪刀，可以精确切割和修饰 DNA 序列。引导 RNA 对于引导 Cas 酶靶向细胞 DNA 序列中的特定基因组位置非常重要。研究人员可能需要针对特定目标设计的自订gRNA，或者他们可能更喜欢预先设计的涵盖模型生物或细胞株中常见基因目标的文库。 CRISPR套件和试剂产品系列包括质体、Cas9蛋白、sgRNA（单嚮导RNA）、表达载体、同源定向修復（HDR）模板、病毒递送系统（如腺结合病毒（AAV）和慢病毒）以及溶核产品包括基于电穿孔的转染方法，包括转染装置和脂转染试剂。细胞株工程服务利用CRISPR技术修饰细胞以引入或增强特定功能，使研究人员能够研究基因功能并开发标靶治疗。这项服务对于专门从事药物发现、基因治疗和再生医学的生物製药公司和学术机构至关重要。引导 RNA (gRNA) 和载体系统的设计和建构对于 CRISPR 介导的基因编辑实验至关重要。研究人员依靠这些服务来产生高效、特异性的敲除或敲入模型，这对于功能基因组学、标靶检验研究和疾病建模等应用尤其重要。基于 CRISPR 的筛检服务对于识别新药物标靶和阐明生物途径中重要的遗传交互作用至关重要。

扩大CRISPR技术在农业领域的应用

在农业领域，CRISPR 技术为作物改良、抗病虫害以及提高产量提供了解决方案。 CRISPR技术也应用于生物医学研究，如遗传疾病的基因治疗、癌症免疫治疗、感染疾病治疗等。 CRISPR技术的工业应用包括微生物工程、生质燃料、生医材料和环境生物修復。

最终用户：CRISPR技术在生技公司的潜在应用

学术和政府研究机构主要专注于CRISPR技术的基础研究和新应用的开发。他们对 CRISPR 的需求将产生先进的知识和工具，以了解基因编辑背后的机制，针对人类基因组中的特定基因，并找到各种遗传疾病的潜在治疗解决方案。使用 CRISPR 技术的生物技术公司专注于商业性应用的应用研究，例如优化工业、增强工业生物过程或直接向消费者销售基因工程产品。製药公司正在将 CRISPR 技术应用于治疗，特别是针对遗传性疾病、癌症和肥胖等文明病的药物发现和药物开发。

区域洞察

在美国，由于广泛的研究和开发活动、公共和私营部门的大量投资以及生物资讯学的进步，CRISPR 技术市场正在经历显着成长。此外，农业、生物技术、药物发现和治疗等强劲且稳定成长的行业正在推动对 CRISPR 技术的需求。亚太地区拥有不断成长的生物製药产业，该产业正在大力投资基因编辑技术，以促进农业进步和疾病治疗应用。此外，政府对基因组学研究的支持以及与国际组织的战略联盟等因素正在加速该地区的市场成长。由于其完善的製药基础设施和各个组织对基因组编辑研究计划的资助，欧洲经历了可观的成长。此外，中东和非洲子区隔放在 CRISPR 在镰镰状性贫血和 β 地中海贫血等疾病的治疗应用。

FPNV定位矩阵

FPNV定位矩阵对于评估CRISPR技术市场至关重要。我们检视与业务策略和产品满意度相关的关键指标，以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估，供应商被分为四个成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对 CRISPR 技术市场中供应商的现状进行深入而详细的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献，以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外，该分析还提供了对该行业竞争特征的宝贵见解，包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。这种详细程度的提高使供应商能够做出更明智的决策并制定有效的策略，从而在市场上获得竞争优势。

本报告在以下方面提供了宝贵的见解：

1. 市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2. 市场开拓：我们深入研究利润丰厚的新兴市场，并分析其在成熟细分市场的渗透率。

3. 市场多元化：提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。

4. 竞争评估和情报：对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况和製造能力进行全面评估。

5. 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告解决了以下关键问题：

1.CRISPR技术市场的市场规模与预测为何？

2.在CRISPR技术市场的预测期间内，有哪些产品、细分市场、应用和领域需要考虑投资？

3.CRISPR技术市场的技术趋势和法规结构是什么？

4. CRISPR技术市场主要厂商的市场占有率是多少？

5.进入CRISPR技术市场的合适型态和策略手段是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 对遗传疾病新疫苗和治疗方法的需求增加
      • 增加对生物技术和製药领域的私人和公共投资
    • 抑制因素
      • 与政府监管相关的高成本和复杂性
    • 机会
      • CRISPR技术的进步与改进
      • CRISPR技术在农业领域的潜在应用
    • 任务
      • 与 CRISPR 技术相关的技术挑战和伦理问题
  • 市场区隔分析
    • 我们提供什么：由于研究活动的激增和产品的改进，CRISPR套件和试剂的使用不断增加。
    • 应用：扩大 CRISPR 技术在农业领域的应用
    • 最终用户：CRISPR技术在生技公司的潜在应用
  • 市场趋势分析
    • 主要参与者加强研发力度，扩大 CRISPR 技术在美洲农业的应用
    • 持续研究和策略合作，利用 CRISPR 技术提高农业生产力，并将 CRISPR 引入亚太地区的就地检验
    • 由于欧洲、中东和非洲地区研究活动的增加，在疾病管理中使用 CRISPR 技术的核准不断增加
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法规结构分析
  • 客户客製化
    • CRISPR 正成为生质能源生产的可行解决方案
    • 扩大 CRISPR 技术的专利版图

第六章 CRISPR 技术市场：透过提供

  • 产品
  • 服务

第七章 CRISPR 技术市场：依应用分类

  • 农业
  • 生物医学
  • 产业

第 8 章 CRISPR 技术市场：按最终用户划分

  • 学术和政府研究机构
  • 生技公司

第九章 美洲CRISPR技术市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章 亚太地区CRISPR技术市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲、中东和非洲的CRISPR技术市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • RoslinCT 生产基于 CRISPR 的治疗方法
    • 第一种人类 CRISPR 药物取得进展
    • ERS Genomics Limited (ERS) 与 Syngene International 签署许可协议
    • Revvity (RVTY) 推出新服务以扩大编辑技术的使用范围
    • Pencil Biosciences 融资 560 万英镑，用于推进罕见疾病的基因编辑
    • 整合式 DNA Technologies 与 Aldevron 建立策略合作伙伴关係，为细胞和基因治疗开发商提供关键 CRISPR 组件
    • Bedoukian Research Inc. 与 Inscripta 合作，可持续开发和生产天然成分。
    • Scribe 宣布合作加速基于 CRISPR 的体内基因药物的开发
    • Vertex 表示计划在 FDA 做出决定之前推出首个 Crispr 基因编辑疗法
    • Sherlock Biosciences 收购 Sense Biodetection
    • Intellia Therapeutics 宣布收购 Relight Therapeutics

第13章竞争产品组合

  • 主要企业简介
  • 主要产品系列
Product Code: MRR-B1685377A648

[183 Pages Report] The CRISPR Technology Market size was estimated at USD 3.25 billion in 2023 and expected to reach USD 3.77 billion in 2024, at a CAGR 16.52% to reach USD 9.49 billion by 2030.

Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) is a highly precise and efficient genome-editing tool derived from a bacterial defense mechanism, which allows for targeted manipulation of the DNA sequence within an organism's genome. This innovative biotechnology tool enables precise genome editing through RNA-guided Cas9 nucleases, facilitating targeted genetic modifications across healthcare, agriculture, and bioenergy industries. Increased funding for research activities, advancements in gene therapy, the growing prevalence of genetic disorders, and the need for more efficient crop production methods increase the use of CRISPR technology. However, ethical concerns surrounding gene editing, especially in human germline cells, and regulatory hurdles in different regions may impede the adoption or commercialization of CRISPR products. Nevertheless, creating new genetically modified crops (GMO) with enhanced nutritional value or resistance to pests and diseases and advancing drug discovery by screening large libraries of compounds against specific targets using CRISPR systems creates lucrative opportunities for the CRISPR technology market.

KEY MARKET STATISTICS
Base Year [2023] USD 3.25 billion
Estimated Year [2024] USD 3.77 billion
Forecast Year [2030] USD 9.49 billion
CAGR (%) 16.52%

Offering: Increasing use of CRISPR kits & reagents with the surging research activities and product improvements

The enzymes used in CRISPR technology are critical components for gene editing, with Cas9 being the most commonly utilized enzyme. These enzymes function as molecular scissors, enabling precise cutting and modification of DNA sequences. Guide RNAs have significance in directing the Cas enzymes to target specific genomic locations within a cell's DNA sequence. Researchers may require custom gRNAs designed for their particular targets or prefer pre-designed libraries that cover common gene targets in model organisms or cell lines. The CRISPR kits & reagent product portfolio comprises a range of products, including plasmids, Cas9 proteins, sgRNAs (single guide RNAs), expression vectors, homology-directed repair (HDR) templates, viral delivery systems such as adeno-associated viruses (AAV) or lentiviruses, electroporation-based transfection methods including nucleofection devices or lipofection reagents. Cell line engineering services involve modifying cells to introduce or enhance specific features using CRISPR technology, enabling researchers to study gene function and develop targeted therapies. This service is crucial for biopharmaceutical companies and academic institutions focused on drug discovery, gene therapy, and regenerative medicine. The design and construction of guide RNAs (gRNAs) and vector systems are essential in CRISPR-mediated gene editing experiments. Researchers rely on these services for generating knockout or knock-in models with high efficiency and specificity, which is particularly important in applications such as functional genomics, target validation studies, and disease modeling. CRISPR-based screening services are pivotal for identifying novel drug targets or uncovering critical genetic interactions within biological pathways.

Application: Proliferating use of CRISPR technology in the agricultural sector

In the agricultural sector, CRISPR technology provides solutions for crop improvement, pest and disease resistance, and increased yield. CRISPR technology has applications in biomedical research, such as gene therapy for genetic disorders, cancer immunotherapy, and infectious disease treatment. The industrial applications of CRISPR technology encompass microbial engineering, biofuels, biomaterials, and environmental bioremediation.

End-User: Potential application of CRISPR technology in biotechnology companies

Academic and government research institutes primarily focus on fundamental research and developing novel applications for CRISPR technology. Their need-based preference for CRISPR revolves around generating advanced knowledge and tools to understand the mechanism behind gene editing, targeting specific genes in the human genome, and finding potential therapeutic solutions for various genetic disorders. Biotechnology companies utilizing CRISPR technology focus on applied research with commercial applications such as agriculture optimization, industrial bioprocessing enhancement, or direct-to-consumer genetic modification products. Pharmaceutical companies involve therapeutic applications of CRISPR technology for drug discovery and development, specifically targeting genetic diseases, cancers, or lifestyle disorders such as obesity.

Regional Insights

In America, the CRISPR technology market represents significant growth due to extensive research and development activities, substantial investments by both public and private sectors, and advances in bioinformatics. In addition, robust and steadily growing sectors such as agriculture, biotechnology, drug discovery, and therapeutics increased demand for CRISPR technology. The APAC region boasts increasing biopharmaceutical industries investing heavily in gene-editing technologies for agricultural advancements and disease treatment applications. Additionally, factors such as government support for genomics research and strategic collaborations with international organizations have accelerated market growth in this region. Europe has experienced considerable growth due to its well-established pharmaceutical infrastructure and funding from various organizations for genome editing research projects. Moreover, the Middle-East and Africa sub-segments focus on therapeutic applications of CRISPR for diseases such as sickle cell anemia and beta-thalassemia.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the CRISPR Technology Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the CRISPR Technology Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the CRISPR Technology Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Applied StemCell, Inc., Beam Therapeutics Inc., Caribou Biosciences, Inc., Cellectis S.A., CRISPR Therapeutics AG, Danaher Corporation, Editas Medicine, Inc., ERS Genomics Limited, Function Oncology, GeneCopoeia, Inc., GenScript Biotech Corporation, Horizon Discovery Group Ltd. by Revvity, Inc., Inscripta, Inc., Intellia Therapeutics, Inc., Lonza Group Ltd., Mammoth Biosciences, Inc., Merck KGaA, New England Biolabs, Inc., OriGene Technologies, Inc., Prime Medicine, Inc., Scribe Therapeutics, Sherlock Biosciences, Inc., Synthego Corporation, Takara Holdings Inc., Thermo Fisher Scientific Inc., ToolGen, Inc., TriLink BioTechnologies by Maravai Intermediate Holdings, LLC, Twist Bioscience Corporation, and Verve Therapeutics, Inc..

Market Segmentation & Coverage

This research report categorizes the CRISPR Technology Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Offering
    • Product
      • Enzymes
      • Guide RNA
      • Kits & Reagents
    • Services
      • Cell Line Engineering
      • gRNA Design & Vector Construction
      • Screening Services
  • Application
    • Agricultural
    • Biomedical
    • Industrial
  • End User
    • Academics & Government Research Institutes
    • Biotechnology Companies
      • Agricultural Companies
      • Pharmaceutical Companies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Georgia
        • Illinois
        • Kentucky
        • Michigan
        • Mississippi
        • New Jersey
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the CRISPR Technology Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the CRISPR Technology Market?

3. What are the technology trends and regulatory frameworks in the CRISPR Technology Market?

4. What is the market share of the leading vendors in the CRISPR Technology Market?

5. Which modes and strategic moves are suitable for entering the CRISPR Technology Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing need for new vaccines and treatments for genetic diseases
      • 5.1.1.2. Increasing private and public investments in biotechnological and pharmaceutical sectors
    • 5.1.2. Restraints
      • 5.1.2.1. High cost and complexities involved in the government regulations
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements and improvements in CRISPR technology
      • 5.1.3.2. Potential use of CRISPR technology in the agriculture sector
    • 5.1.4. Challenges
      • 5.1.4.1. Technical challenges and ethical concerns associated with CRISPR technology
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Offering: Increasing use of CRISPR kits & reagents with the surging research activities and product improvements
    • 5.2.2. Application: Proliferating use of CRISPR technology in the agricultural sector
    • 5.2.3. End-User: Potential application of CRISPR technology in biotechnology companies
  • 5.3. Market Trend Analysis
    • 5.3.1. Increasing research and development by key players and growing application of CRISPR technology in agriculture in the Americas
    • 5.3.2. Ongoing research and strategic collaborations for higher agricultural productivity using CRISPR technologies coupled with adoption of CRISPR in point-of-care testing in the APAC region
    • 5.3.3. Increasing approvals for the usage of CRISPR technology for disease management coupled with growing research activities in the EMEA region
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework Analysis
  • 5.8. Client Customization
    • 5.8.1. CRISPR becoming a viable solution for bioenergy production
    • 5.8.2. Expanding patent landscape for CRISPR technology

6. CRISPR Technology Market, by Offering

  • 6.1. Introduction
  • 6.2. Product
  • 6.3. Services

7. CRISPR Technology Market, by Application

  • 7.1. Introduction
  • 7.2. Agricultural
  • 7.3. Biomedical
  • 7.4. Industrial

8. CRISPR Technology Market, by End User

  • 8.1. Introduction
  • 8.2. Academics & Government Research Institutes
  • 8.3. Biotechnology Companies

9. Americas CRISPR Technology Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific CRISPR Technology Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa CRISPR Technology Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. RoslinCT Manufacture CRISPR-Based Therapy
    • 12.3.2. First Human CRISPR Drug Moves Forward
    • 12.3.3. ERS Genomics Limited ('ERS') Completes Licensing Agreement With Syngene International
    • 12.3.4. Revvity's (RVTY) New Launch to Widen Access to Editing Technology
    • 12.3.5. Pencil Biosciences Raises GBP 5.6 Million to Advance Gene Editing for Rare Diseases
    • 12.3.6. Integrated DNA Technologies and Aldevron Activate Strategic Partnership to Deliver Key CRISPR Components to Cell and Gene Therapy Developers
    • 12.3.7. Bedoukian Research Inc. Partners with Inscripta to Sustainably Develop and Manufacture Naturally Produced Ingredients
    • 12.3.8. Scribe Announces Collaboration to Accelerate In Vivo CRISPR-Based Genetic Medicines
    • 12.3.9. Vertex Teases Launch Plans for First Crispr Gene Editing Therapy Ahead of FDA Decision
    • 12.3.10. Sherlock Biosciences to Acquire Sense Biodetection
    • 12.3.11. Intellia Therapeutics Announces Acquisition of Rewrite Therapeutics

13. Competitive Portfolio

  • 13.1. Key Company Profiles
  • 13.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. CRISPR TECHNOLOGY MARKET RESEARCH PROCESS
  • FIGURE 2. CRISPR TECHNOLOGY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. CRISPR TECHNOLOGY MARKET DYNAMICS
  • FIGURE 7. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS CRISPR TECHNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS CRISPR TECHNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES CRISPR TECHNOLOGY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES CRISPR TECHNOLOGY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC CRISPR TECHNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC CRISPR TECHNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CRISPR TECHNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CRISPR TECHNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. CRISPR TECHNOLOGY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 22. CRISPR TECHNOLOGY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CRISPR TECHNOLOGY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY ENZYMES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY ENZYMES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY GUIDE RNA, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY GUIDE RNA, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY KITS & REAGENTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY KITS & REAGENTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY CELL LINE ENGINEERING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY CELL LINE ENGINEERING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY GRNA DESIGN & VECTOR CONSTRUCTION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY GRNA DESIGN & VECTOR CONSTRUCTION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY SCREENING SERVICES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY SCREENING SERVICES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY AGRICULTURAL, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY AGRICULTURAL, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY BIOMEDICAL, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY BIOMEDICAL, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY INDUSTRIAL, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY INDUSTRIAL, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY ACADEMICS & GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY ACADEMICS & GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY AGRICULTURAL COMPANIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY AGRICULTURAL COMPANIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 47. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 48. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 49. AMERICAS CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 50. AMERICAS CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 51. AMERICAS CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 52. AMERICAS CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 53. AMERICAS CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 54. AMERICAS CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 55. AMERICAS CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 56. AMERICAS CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 57. AMERICAS CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 58. AMERICAS CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 59. AMERICAS CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2023 (USD MILLION)
  • TABLE 60. AMERICAS CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2024-2030 (USD MILLION)
  • TABLE 61. AMERICAS CRISPR TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 62. AMERICAS CRISPR TECHNOLOGY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 63. ARGENTINA CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 64. ARGENTINA CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 65. ARGENTINA CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 66. ARGENTINA CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 67. ARGENTINA CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 68. ARGENTINA CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 69. ARGENTINA CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 70. ARGENTINA CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 71. ARGENTINA CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 72. ARGENTINA CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 73. ARGENTINA CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2023 (USD MILLION)
  • TABLE 74. ARGENTINA CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2024-2030 (USD MILLION)
  • TABLE 75. BRAZIL CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 76. BRAZIL CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 77. BRAZIL CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 78. BRAZIL CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 79. BRAZIL CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 80. BRAZIL CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 81. BRAZIL CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 82. BRAZIL CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 83. BRAZIL CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 84. BRAZIL CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 85. BRAZIL CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2023 (USD MILLION)
  • TABLE 86. BRAZIL CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2024-2030 (USD MILLION)
  • TABLE 87. CANADA CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 88. CANADA CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 89. CANADA CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 90. CANADA CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 91. CANADA CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 92. CANADA CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 93. CANADA CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 94. CANADA CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 95. CANADA CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 96. CANADA CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 97. CANADA CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2023 (USD MILLION)
  • TABLE 98. CANADA CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2024-2030 (USD MILLION)
  • TABLE 99. MEXICO CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 100. MEXICO CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 101. MEXICO CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 102. MEXICO CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 103. MEXICO CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 104. MEXICO CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 105. MEXICO CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 106. MEXICO CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 107. MEXICO CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 108. MEXICO CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 109. MEXICO CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2023 (USD MILLION)
  • TABLE 110. MEXICO CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2024-2030 (USD MILLION)
  • TABLE 111. UNITED STATES CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 112. UNITED STATES CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 113. UNITED STATES CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 114. UNITED STATES CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 115. UNITED STATES CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 116. UNITED STATES CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 117. UNITED STATES CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 118. UNITED STATES CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 119. UNITED STATES CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 120. UNITED STATES CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 121. UNITED STATES CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2023 (USD MILLION)
  • TABLE 122. UNITED STATES CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2024-2030 (USD MILLION)
  • TABLE 123. UNITED STATES CRISPR TECHNOLOGY MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 124. UNITED STATES CRISPR TECHNOLOGY MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 125. ASIA-PACIFIC CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 128. ASIA-PACIFIC CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 131. ASIA-PACIFIC CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 134. ASIA-PACIFIC CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2023 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2024-2030 (USD MILLION)
  • TABLE 137. ASIA-PACIFIC CRISPR TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC CRISPR TECHNOLOGY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 139. AUSTRALIA CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 140. AUSTRALIA CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 141. AUSTRALIA CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 142. AUSTRALIA CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 143. AUSTRALIA CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 144. AUSTRALIA CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 145. AUSTRALIA CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 146. AUSTRALIA CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 147. AUSTRALIA CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 148. AUSTRALIA CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 149. AUSTRALIA CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2023 (USD MILLION)
  • TABLE 150. AUSTRALIA CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2024-2030 (USD MILLION)
  • TABLE 151. CHINA CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 152. CHINA CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 153. CHINA CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 154. CHINA CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 155. CHINA CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 156. CHINA CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 157. CHINA CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 158. CHINA CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 159. CHINA CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 160. CHINA CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 161. CHINA CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2023 (USD MILLION)
  • TABLE 162. CHINA CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2024-2030 (USD MILLION)
  • TABLE 163. INDIA CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 164. INDIA CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 165. INDIA CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 166. INDIA CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 167. INDIA CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 168. INDIA CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 169. INDIA CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 170. INDIA CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 171. INDIA CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 172. INDIA CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 173. INDIA CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2023 (USD MILLION)
  • TABLE 174. INDIA CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2024-2030 (USD MILLION)
  • TABLE 175. INDONESIA CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 176. INDONESIA CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 177. INDONESIA CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 178. INDONESIA CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 179. INDONESIA CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 180. INDONESIA CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 181. INDONESIA CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 182. INDONESIA CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 183. INDONESIA CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 184. INDONESIA CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 185. INDONESIA CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2023 (USD MILLION)
  • TABLE 186. INDONESIA CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2024-2030 (USD MILLION)
  • TABLE 187. JAPAN CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 188. JAPAN CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 189. JAPAN CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 190. JAPAN CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 191. JAPAN CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 192. JAPAN CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 193. JAPAN CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 194. JAPAN CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 195. JAPAN CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 196. JAPAN CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 197. JAPAN CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2023 (USD MILLION)
  • TABLE 198. JAPAN CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2024-2030 (USD MILLION)
  • TABLE 199. MALAYSIA CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 200. MALAYSIA CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 201. MALAYSIA CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 202. MALAYSIA CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 203. MALAYSIA CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 204. MALAYSIA CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 205. MALAYSIA CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 206. MALAYSIA CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 207. MALAYSIA CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 208. MALAYSIA CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 209. MALAYSIA CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2023 (USD MILLION)
  • TABLE 210. MALAYSIA CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2024-2030 (USD MILLION)
  • TABLE 211. PHILIPPINES CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 212. PHILIPPINES CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 213. PHILIPPINES CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 214. PHILIPPINES CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 215. PHILIPPINES CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 216. PHILIPPINES CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 217. PHILIPPINES CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 218. PHILIPPINES CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 219. PHILIPPINES CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 220. PHILIPPINES CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 221. PHILIPPINES CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2023 (USD MILLION)
  • TABLE 222. PHILIPPINES CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2024-2030 (USD MILLION)
  • TABLE 223. SINGAPORE CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 224. SINGAPORE CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 225. SINGAPORE CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 226. SINGAPORE CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 227. SINGAPORE CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 228. SINGAPORE CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 229. SINGAPORE CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 230. SINGAPORE CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 231. SINGAPORE CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 232. SINGAPORE CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 233. SINGAPORE CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2023 (USD MILLION)
  • TABLE 234. SINGAPORE CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2024-2030 (USD MILLION)
  • TABLE 235. SOUTH KOREA CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 236. SOUTH KOREA CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 237. SOUTH KOREA CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 238. SOUTH KOREA CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 239. SOUTH KOREA CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 240. SOUTH KOREA CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 241. SOUTH KOREA CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 242. SOUTH KOREA CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 243. SOUTH KOREA CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 244. SOUTH KOREA CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 245. SOUTH KOREA CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2023 (USD MILLION)
  • TABLE 246. SOUTH KOREA CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2024-2030 (USD MILLION)
  • TABLE 247. TAIWAN CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 248. TAIWAN CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 249. TAIWAN CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 250. TAIWAN CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 251. TAIWAN CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 252. TAIWAN CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 253. TAIWAN CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 254. TAIWAN CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 255. TAIWAN CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 256. TAIWAN CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 257. TAIWAN CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2023 (USD MILLION)
  • TABLE 258. TAIWAN CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2024-2030 (USD MILLION)
  • TABLE 259. THAILAND CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 260. THAILAND CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 261. THAILAND CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 262. THAILAND CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 263. THAILAND CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 264. THAILAND CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 265. THAILAND CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 266. THAILAND CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 267. THAILAND CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 268. THAILAND CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 269. THAILAND CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2023 (USD MILLION)
  • TABLE 270. THAILAND CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2024-2030 (USD MILLION)
  • TABLE 271. VIETNAM CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 272. VIETNAM CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 273. VIETNAM CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 274. VIETNAM CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 275. VIETNAM CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 276. VIETNAM CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 277. VIETNAM CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 278. VIETNAM CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 279. VIETNAM CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 280. VIETNAM CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 281. VIETNAM CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2023 (USD MILLION)
  • TABLE 282. VIETNAM CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2024-2030 (USD MILLION)
  • TABLE 283. EUROPE, MIDDLE EAST & AFRICA CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 284. EUROPE, MIDDLE EAST & AFRICA CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 285. EUROPE, MIDDLE EAST & AFRICA CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 286. EUROPE, MIDDLE EAST & AFRICA CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 287. EUROPE, MIDDLE EAST & AFRICA CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 288. EUROPE, MIDDLE EAST & AFRICA CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 289. EUROPE, MIDDLE EAST & AFRICA CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 290. EUROPE, MIDDLE EAST & AFRICA CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 291. EUROPE, MIDDLE EAST & AFRICA CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 292. EUROPE, MIDDLE EAST & AFRICA CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 293. EUROPE, MIDDLE EAST & AFRICA CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2023 (USD MILLION)
  • TABLE 294. EUROPE, MIDDLE EAST & AFRICA CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2024-2030 (USD MILLION)
  • TABLE 295. EUROPE, MIDDLE EAST & AFRICA CRISPR TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 296. EUROPE, MIDDLE EAST & AFRICA CRISPR TECHNOLOGY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 297. DENMARK CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 298. DENMARK CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 299. DENMARK CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 300. DENMARK CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 301. DENMARK CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 302. DENMARK CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 303. DENMARK CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 304. DENMARK CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 305. DENMARK CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 306. DENMARK CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 307. DENMARK CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2023 (USD MILLION)
  • TABLE 308. DENMARK CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2024-2030 (USD MILLION)
  • TABLE 309. EGYPT CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 310. EGYPT CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 311. EGYPT CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 312. EGYPT CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 313. EGYPT CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 314. EGYPT CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 315. EGYPT CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 316. EGYPT CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 317. EGYPT CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 318. EGYPT CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 319. EGYPT CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2023 (USD MILLION)
  • TABLE 320. EGYPT CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2024-2030 (USD MILLION)
  • TABLE 321. FINLAND CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 322. FINLAND CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 323. FINLAND CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 324. FINLAND CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 325. FINLAND CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 326. FINLAND CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 327. FINLAND CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 328. FINLAND CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 329. FINLAND CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 330. FINLAND CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 331. FINLAND CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2023 (USD MILLION)
  • TABLE 332. FINLAND CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2024-2030 (USD MILLION)
  • TABLE 333. FRANCE CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 334. FRANCE CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 335. FRANCE CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 336. FRANCE CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 337. FRANCE CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 338. FRANCE CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 339. FRANCE CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 340. FRANCE CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 341. FRANCE CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 342. FRANCE CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 343. FRANCE CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2023 (USD MILLION)
  • TABLE 344. FRANCE CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2024-2030 (USD MILLION)
  • TABLE 345. GERMANY CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 346. GERMANY CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 347. GERMANY CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 348. GERMANY CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 349. GERMANY CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 350. GERMANY CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 351. GERMANY CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 352. GERMANY CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 353. GERMANY CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 354. GERMANY CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 355. GERMANY CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2023 (USD MILLION)
  • TABLE 356. GERMANY CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2024-2030 (USD MILLION)
  • TABLE 357. ISRAEL CRISPR TEC